Skip to main content

Obsidian Therapeutics, Inc.

OBX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002130606

No open-market purchases or sales by Obsidian Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Superinvestors holding OBX, Q2 2026

See all superinvestors

No superinvestor reported holding OBX in Q2 2026.